Trials of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Lack Strategies to Ensure Appropriate Gastroprotection.
Trials of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Lack Strategies to Ensure Appropriate Gastroprotection.
复制标题
DOI：
10.14309/ajg.0000000000001134
复制
发表时间：
2021-04
期刊：
影响因子：
--
通讯作者：
Saini SD
中科院分区：
文献类型：
--
作者：
Kurlander JE;Barnes GD;Sukul D;Helminski D;Kokaly AN;Platt K;Gurm H;Saini SD
Gastrointestinal bleeding is a morbid complication of dual antiplatelet therapy (DAPT). We evaluated the extent to which contemporary trials of DAPT included steps to ensure appropriate use of proton pump inhibitor (PPI) gastroprotection and reported rates of PPI use. A methodological review of randomized trials comparing varying durations of DAPT after percutaneous coronary intervention. Among 21 trials, none incorporated protocol procedures or guidance for prescribing PPIs. Five reported rates of PPI use (range 25.6-69.1%). PPI gastroprotection is overlooked in major trials of DAPT. Appropriate use of PPI gastroprotection represents an important opportunity to improve patient safety.
登录
查看更多内容
影响因子：
158.5
作者：
Bhatt, Deepak L.;Cryer, Byron L.;Cannon, Christopher P.
通讯作者：
Cannon, Christopher P.
影响因子：
37.8
作者：
Berger, Peter B.;Bhatt, Deepak L.;Topol, Eric J.
通讯作者：
Topol, Eric J.
影响因子：
24
作者：
Levine, Glenn N.;Bates, Eric R.;Hundley, Jody
通讯作者：
Hundley, Jody
影响因子：
37.8
作者：
Garcia Rodriguez, Luis A.;Joshua Lin, Kueiyu;Johansson, Saga
通讯作者：
Johansson, Saga
影响因子：
37.8
作者：
Abraham, Neena S.;Hlatky, Mark A.;Wesley, Deborah J.
通讯作者：
Wesley, Deborah J.